Boehringer Ingelheim has reported encouraging Phase II trial results for apecotrep (BI 764198), a potential first-in-class oral TRPC6 inhibitor being developed for primary focal segmental ...
Airbus Defence and Space and Hisdesat have signed an agreement to extend their strategic partnership for the commercialisation of radar Earth observation imagery, covering the future PAZ-2 satellite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results